An observational study suggests that routine platelet measurements during pregnancy may help identify women who do not respond to low-dose aspirin and subsequently develop preeclampsia. The findings indicate that monitoring platelet indices may assist in identifying women unlikely to benefit from aspirin therapy, supporting early identification of high-risk pregnancies for tailored intervention.

Source: BMC Medicine